Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2018 3
2019 4
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
von Essen MR, Ammitzbøll C, Hansen RH, Petersen ERS, McWilliam O, Marquart HV, Damm P, Sellebjerg F. von Essen MR, et al. Among authors: mcwilliam o. Brain. 2019 Jan 1;142(1):120-132. doi: 10.1093/brain/awy301. Brain. 2019. PMID: 30561509 Clinical Trial.
MAIT cell subtypes in multiple sclerosis.
Ammitzbøll C, von Essen MR, Chow HH, McWilliam O, Holm Hansen R, Sellebjerg F. Ammitzbøll C, et al. Among authors: mcwilliam o. J Neuroimmunol. 2020 Feb 15;339:577117. doi: 10.1016/j.jneuroim.2019.577117. Epub 2019 Nov 20. J Neuroimmunol. 2020. PMID: 31812897
Natalizumab differentially affects plasmablasts and B cells in multiple sclerosis.
Cuculiza Henriksen A, Ammitzbøll C, Petersen ER, McWilliam O, Sellebjerg F, von Essen MR, Romme Christensen J. Cuculiza Henriksen A, et al. Among authors: mcwilliam o. Mult Scler Relat Disord. 2021 Jul;52:102987. doi: 10.1016/j.msard.2021.102987. Epub 2021 May 1. Mult Scler Relat Disord. 2021. PMID: 33984651